On March 31, 2025 Circle Pharma, a clinical-stage biopharmaceutical company focused on developing cell-permeable macrocycle therapeutics, reported that Chief Executive Officer David Earp, JD, Ph.D., will present at the following investor conferences (Press release, Circle Pharma, MAR 31, 2025, View Source;utm_medium=rss&utm_campaign=circle-pharma-to-present-at-the-upcoming-investor-conferences [SID1234651665]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

24th Annual Needham Virtual Healthcare Conference
April 9, 2025

11:45 – 12:25 pm ET

Stifel 2025 Virtual Targeted Oncology Forum
April 9, 2025

1:30 p.m. – 1:55 p.m. ET